Login or register to access the content restricted to healthcare professionals only

Bod MediCabilis™ Phase I clinical  study

Bod Australia has invested in phase 1 clinical study that assessed the safety, tolerability and pharmacokinetics of the Bod MediCabilis™ 5% CBD Cannabis sativa, full-spectrum extract in oil.

The research was conducted at Nucleus Network and published in the prestigious British Journal of Clinical Pharmacology.

Read more